We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Raging Bull Investments’ Substack by Jake LaMotta. In this article we will summarize the bulls’ thesis on MREO. Mereo BioPharma Group plc (MREO) share was trading at $3.95 as of Sept 17th.
Pixabay/Public domain
Mereo BioPharma is positioning itself as a key player in rare diseases, with Ultragenyx recently providing a highly optimistic update on setrusumab’s phase 3 trials for osteogenesis imperfecta (OI). The...
